Press release
Global Hyperemesis Gravidarum Treatment Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028
Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=2183
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price of drugs may hinder the growth of the hyperemesis gravidarum treatment market.
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and anti-hitamines medications. Sometimes, in case of hospitalization intravenous fluid is given to the mother to restore the electrolyte balance, nutrients, and vitamins. Hyperemesis gravidarum treatment depends on the severity of symptoms in patients. Hyperemesis gravidarum needs to be diagnosed as early as possible to reduce the risk of morbidity of both mother and foetus.
As per a recent literature survey conducted by the State University of New York (SUNY) reveals that approximately 0.3 to 3% of pregnancy cases need hyperemesis gravidarum treatment.
To know more about the Hyperemesis Gravidarum Treatment Market Visit the link- https://www.factmr.com/report/2183/hyperemesis-gravidarum-treatment-market
Hyperemesis Gravidarum Treatment Market: Overview
The dietary supplements and anti-emetic medications are expected to generate significant revenue over the forecast in the global hyperemesis gravidarum treatment market, followed by prokinetic agents. People prefer OTC products rather than prescription drugs for hyperemesis gravidarum treatment, which is expected to drive the growth of the retail segment over the forecast period. Based on RoA, intravenous treatment is gaining popularity for hyperemesis gravidarum treatment because in this way the drugs directly get absorbed into the blood-stream, leaving no option to irritate the gastric mucosa. Some of the popular brands of hyperemesis gravidarum treatment include Diclectin (Duchesnay Inc.), Pregvit (Duchesnay Inc.), Zofran (Novartis AG), Zuplenz (Midatech Pharma US Inc.), Kytril (Genentech, Inc.), etc.
Hyperemesis Gravidarum Treatment Market: Regional Outlook
Geographically, the global hyperemesis gravidarum treatment market is segmented into North America, Latin America, Europe, CIS & Russia, Asia-Pacific Excluding Japan, Japan and the Middle East & Africa. North America is expected to be the dominant regional market for hyperemesis gravidarum treatment due to the growing awareness regarding use of prescription drugs. Europe is expected to contribute second large revenue share in the global hyperemesis gravidarum treatment market throughout the forecast period due increasing number of patients with need of hyperemesis gravidarum treatment. With increase in the expenditure for healthcare sector and growing awareness regarding hyperemesis gravidarum treatment among general population, the hyperemesis gravidarum treatment market is expected to grow at a significant CAGR in Asia Pacific.
Hyperemesis Gravidarum Treatment: Key Players
The global Hyperemesis Gravidarum Treatment is highly fragmented with a large number of global players operating. Examples of some of the key players identified in the global hyperemesis gravidarum treatment market are Duchesnay Inc., Ipca Laboratories Ltd., Medichem S.A., Novartis AG, Midatech Pharma US Inc., and Genentech, Inc., among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=2183
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - http://theguardiantribune.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hyperemesis Gravidarum Treatment Market Projected to Augment at a Notable CAGR during the Forecast Period until 2028 here
News-ID: 1653683 • Views: 249
More Releases from Fact.MR
Fishing Rods Market to Expand 1.6X by 2030; Decline in Sales Predicted Throughou …
The fishing rods market is poised to expand at a value CAGR of 4.5%, and is expected to create an absolute dollar opportunity of US$ 1.5 Bn during the forecast duration of 2020-2030. The outbreak of COVID-19 will have a short-term impact on the fishing rods market. However, rising participation in fishing activities and increasing fishing boat sales will drive the growth the fishing rods market over the coming years.…
Fishing Reels Market Pegged for Robust Expansion by 2030
Rising number of recreational and sports fishing anglers, especially in North America and East Asia, is set to drive demand for fishing reels and other fishing associated accessories. Growth rate with respect to number of recreational anglers at a global level is expected to be 2.3% over the next ten years. Further, social media has silently elevated demand across several industries, including sports fishing equipment. Anglers post about their catch…
Fishing Lure Market to Witness a Pronounce Growth by 2030
The spread of COVID-19 is resulting in declining sales as most anglers are staying indoors. To overcome this situation, manufacturers are utilizing digital technologies and engaging customers via online portals. As such, the outbreak of this pandemic has shifted consumer focus to e-Commerce platforms. This, in turn, will strengthen demand for fishing lures over the forecast period.
Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5293
There has been significant…
Denture Disinfectants Market Surges on the Back of Growing Edentulous Population …
A significant rise in edentulous population has been observed over the last few years. As per data from the American college of Prosthodontists, around 14% of edentulous population in North America orders customized dentures every year. More than 35% of U.S. adults are edentulous, and if only one percent of edentulous population seek treatment every year, the U.S. market volume for denture implants will be doubled in the next two…
More Releases for Hyperemesis
Global Hyperemesis Gravidarum Market Projections Analyzed To Inspect Growth Tren …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price…
Global Hyperemesis Gravidarum Treatment Market Scenario Highlighting Major Drive …
The global market for hyperemesis gravidarum treatment is expected to witness significant growth over the forecast period as the demand for prescription drugs over the OTCs for hyperemesis gravidarum treatment is high in developing countries, as they have less side effects and better efficacy. Increasing prevalence of HG among pregnant women is the other factor expected to drive the growth of the Hyperemesis Gravidarum Treatment Market. However, the high price…
Central Pontine Myelinolysis Market Treatment Methods Analysis 2019 with Key Pla …
The market drivers for Central Pontine Myelinolysis Market are increasing risk factors and cases of liver disease, liver transplant, alcoholism, severe burns, malnutrition, anorexia, severe electrolyte disorders, AIDS, hyperemesis gravidarum, anorexia nervosa, hematopoietic stem cell transplantation, Wernicke encephalopathy etc. The market restraints are poor cure rates of central pontine myelinolysis, treatment, high cost of treatment etc.
Global Central Pontine Myelinolysis Market - Key players
Some of key players profiled in the report…
Central Pontine Myelinolysis Market with Major Players Like Fujifilm Holdings Co …
Central pontine myelinolysis (CPM), also known as osmotic demyelination syndrome or central pontine demyelination, is a neurological disorder caused by severe damage of the myelin sheath of nerve cells. CPM mostly affects the pons area of the brain and is characterized by acute paralysis, difficulty swallowing (dysphagia), difficulty speaking (dysarthria), and other neurological symptoms. These neurological symptoms are manifested into nausea and vomiting, disturbed consciousness, gait changes, confusion, headache, seizures…
Growth Predictions on Global Hyperemesis Gravidarum Treatment Market Through 202 …
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and…
Hyperemesis Gravidarum Treatment Market Projected to Experience Major Revenue Bo …
Hyperemesis gravidarum (HG) is the most prevalent cause of hospitalization during the course of pregnancy (mainly first half). Hyperemesis gravidarum is characterized by severe electrolyte imbalance due to nausea, vomiting. Till date, the exact etiology of hyperemesis gravidarum is not known. For mild cases of hyperemesis gravidarum the treatments include use of antacids, rest and some dietary changes. Severe cases often need hospitalization. Hyperemesis gravidarum treatment includes metoclopramide, anti-reflux, and…
